Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05388643 · ClinicalTrials.gov registry record · NA

Early Detection of Gestational Diabetes Mellitus in Pregnancy

A NA study of Pregnancy, High Risk and Gestational Diabetes Mellitus in Pregnancy, sponsored by University of Massachusetts, Worcester.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05388643 is a NA study of Pregnancy, High Risk and Gestational Diabetes Mellitus in Pregnancy that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 80 participants, below the 313-participant average among 20 other Pregnancy, High Risk trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05388643, a NA study of Pregnancy, High Risk and Gestational Diabetes Mellitus in Pregnancy, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop an implementation protocol and test the feasibility and acceptability of a first trimester screening protocol for the early detection of gestational diabetes mellitus (GDM).

Interventions

  • DIAGNOSTIC_TEST Enhanced First Trimester GDM Screening
  • DIAGNOSTIC_TEST Routine Gestational Diabetes Screening

Study Locations (1)

Massachusetts

  • University of Massachusetts Memorial Medical Center - Worcester

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-08-18
Est. Completion 2026-12-01
Phase NA

What the Registry Record Tells You About NCT05388643

The ClinicalTrials.gov registry entry for NCT05388643 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 313-participant average among 20 other Pregnancy, High Risk trials with a reported enrollment target (74% lower). The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pregnancy, High Risk appearing as the primary indexed condition, and to 2 interventions - of which Enhanced First Trimester GDM Screening is the first listed.

NCT05388643 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05388643 about?

NCT05388643 is a clinical study titled "Early Detection of Gestational Diabetes Mellitus in Pregnancy". The purpose of this study is to develop an implementation protocol and test the feasibility and acceptability of a first trimester screening protocol for the early detection of gestational diabetes mellitus (GDM).

What is the current status of trial NCT05388643?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-08-18. Estimated completion is 2026-12-01.

What conditions does trial NCT05388643 study?

This clinical trial studies the following conditions: Pregnancy, High Risk, Gestational Diabetes Mellitus in Pregnancy.

What interventions are being tested in trial NCT05388643?

The interventions under investigation include: Enhanced First Trimester GDM Screening (DIAGNOSTIC_TEST), Routine Gestational Diabetes Screening (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05388643?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05388643 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy, High Risk

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.